Evidence map›Paper›PMID 42057464›Full record

ArticleCancer medicine2026

Cancer Incidence in People With Intellectual Disability and Down Syndrome in Australia: A Cohort Study.

Julian Trofimovs, Claire M Vajdic, Preeyaporn Srasuebkul, Sallie-Anne Pearson, Julian N Trollor

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julian TrofimovsNational Centre of Excellence in Intellectual Disability Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0001-8278-626X
Claire M VajdicThe Kirby Institute, University of New South Wales, Sydney, Australia.
Preeyaporn SrasuebkulNational Centre of Excellence in Intellectual Disability Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0002-6252-1368
Sallie-Anne PearsonCentre for Big Data Research in Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0001-7137-6855
Julian N TrollorNational Centre of Excellence in Intellectual Disability Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0002-7685-2977

Funding

Aspen Medical FoundationNational Health and Medical Research Council 1123033
6 · The paper itself

Abstract

objectiveThere is inconsistent data on cancer risk in people with intellectual disability. Our primary objective was to compare the incidence of cancer in people with and without intellectual disability. METHODS AND ANALYSIS: A cohort study using linked population-based administrative and cancer registry data in New South Wales, Australia 2001-2018. We compared the incidence of cancer in people with intellectual disability and a comparator group without intellectual disability matched for age, sex and residential postcode. We also compared cancer incidence in people with Down syndrome and people with intellectual disability without Down syndrome. We used a flexible parametric survival model accounting for competing risks.

resultsPeople with intellectual disability had a slightly higher risk of developing any cancer (sub-hazard ratio, SHR 1.07 [95% CI 1.03 to 1.12]) compared to those without intellectual disability. An increased risk was evident in the 0-14 year (SHR 2.19, 95% CI 1.85 to 2.59) and 15-49 year (SHR 1.34, 95% CI 1.23 to 1.46) age groups, and a decreased risk was observed for those aged 50 years and above (SHR 0.93, 95% CI 0.88 to 0.98). People with intellectual disability had a higher risk of colorectal cancer (SHR 1.32, 95% CI 1.15 to 1.51) and a lower risk of prostate cancer (SHR 0.45, 95% CI 0.38 to 0.53) and melanoma (SHR 0.75, 95% CI 0.64 to 0.88). People with Down syndrome had a significantly higher risk of childhood cancer (SHR 7.94, 95% CI 5.72 to 11.04) compared to those with other intellectual disability, and a similar risk as an adult.

conclusionsThese findings underscore the need for targeted health promotion campaigns and, for adults, customised cancer screening programmes to improve access, acceptability and outcomes for people with intellectual disability.

Indexed as

Down SyndromeIntellectual DisabilityNeoplasmsAdolescentAdultAgedAustraliaChildChild, PreschoolCohort StudiesFemaleHumansIncidenceInfantInfant, NewbornMalecancercancer screeningcohortdisabilityDown syndromeintellectual disabilitylinkage

Identifiers

PMID42057464
PMCPMC13129230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.